Krystal Biotech has paused enrollment of its trial testing the intratumoral form of its experimental cancer drug KB707, citing a shift in development. The decision comes ahead of a scheduled end-of-phase-2 meeting with the FDA in October, during which the…

The FDA suspended the license for vaccine manufacturer Valneva’s chikungunya vaccine following reports of serious adverse events.  The decision halts all shipping and sales of the vaccine in the U.S., effective immediately, according to an Aug. 25 news release from…

The FDA has accepted Stealth BioTherapeutics’ resubmission of its new drug application for elamipretide, a treatment for Barth syndrome.  The agency set an earlier review target date of Sept. 26, ahead of the Feb. 15 deadline, according to an Aug.…

A study has found that adults with obesity taking GLP-1 receptor agonists may face significantly lower risk of developing certain cancers.  The cohort study was led by researchers from the Indiana School of Medicine in Indianapolis and the University of…

More than three decades ago, Congress created the 340B program to help safety-net hospitals and clinics​​ expand resources and care for underserved communities.  By requiring pharmaceutical companies to offer deep discounts on outpatient drugs, the program has become a hallmark…

The rising cost of medications is turning into a financial gut punch for hospitals, with pharmaceutical spending driving tens of millions of dollars in losses across health systems.  In the first half of 2025, New York City-based Memorial Sloan Kettering…

Independent pharmacies in the U.S. saw nearly equivalent numbers of openings and closures, indicating a stable and healthy rate of market churn, according to a study published Aug. 1 in JAMA Health Forum.  The research analyzed more than 60,000 community…

A cross-sectional study found that while the Inflation Reduction Act capped out-of-pocket drug costs for Medicare Part D beneficiaries at $2,000 starting in 2025, many enrollees may still face higher cost-sharing due to changes in plan design.  The research, published…

A federal judge has ordered CVS Caremark to pay nearly $290 million in damages after determining the pharmacy benefit manager overbilled Medicare for prescription drugs, according to court documents reviewed by Becker’s.  Four notes:  “We are pleased that the Behnke…

The Joint Commission of Pharmacy Practitioners released an updated version of the Pharmacists’ Patient Care Process, replacing the original framework established in 2014.  The update is the result of a two-year review led by a group of representatives from 14…